Corramedical, an EvoNexus Portfolio Company, Announces Formation of Scientific Advisory Board
Corramedical, an EvoNexus Portfolio Company, Announces Formation of Scientific Advisory Board To Accelerate Company’s Mission to Make Precision Medicine Available to More Patients; Thought Leaders in Pathology, Oncology, Radiology, and […]
EvoNexus 2025 Portfolio Venture Funding on Track for Record-Breaking Year
EvoNexus 2025 Portfolio Venture Funding on Track for Record-Breaking Year “When Vice Admiral Walter Davis and I founded EvoNexus in 2010, our initial goal was first to see if the […]
EvoNexus Graduate, Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health
EvoNexus Graduate, Biolinq Announces Close of $100M Series C Financing to Advance Its Biowearable Platform for Metabolic Health The Series C funding supports Biolinq’s transition from development stage to commercial […]
EvoNexus Company, CureMetrix, Partners with Volpara Health to Enhance AI-Driven Mammography Solutions for Breast Cancer Screening
CureMetrix and Volpara Health x Lunit Enter Agreement to Expand Access to cmAngio Enhancing Women’s Health: CureMetrix cmAngio is now available to thousands of providers through Volpara “CureMetrix entered in […]
EvoNexus & Procopio Event: MDs on the Front Line
RSVP Here! Whether it’s indications of a potential heart attack, drug overdose, auto-accidents, crime related injuries, or a pandemic event, the ER doctors see it all. The technology utilized in […]
Evo Company, MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems With its Remote Care Management Platform
Evo Company, MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems With its Remote Care Management Platform BUSINESS WIRE / SAN DIEGO, CA / APRIL 10TH, 2024 / […]
EvoNexus Graduate, Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology
EvoNexus Graduate, Biolinq Raises $58 Million to Advance Wearable Biosensors Through Pivotal Trial for Metabolic Health Using Precision Microsensor Technology Biosensor platform leverages silicon semiconductor manufacturing for scale. Technology designed […]